help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 8, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0138
A more recent version of this article appeared on July 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/7/1537    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deng, L.
Right arrow Articles by Frank, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deng, L.
Right arrow Articles by Frank, S. J.

Submitted on March 13, 2007
Accepted on April 30, 2007

DETERMINANTS OF GROWTH HORMONE RECEPTOR DOWNREGULATION

Luqin Deng, Kai He, Xiangdong Wang, Ning Yang, Chellappagounder Thangavel, Jing Jiang, Serge Y. Fuchs, and Stuart J. Frank*

Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL, 35294-0012; Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL, 35294-0012; Department of Animal Biology, University of Pennsylvania, Philadelphia, PA 19104-6046; Endocrinology Section, Medical Service, Veterans Affairs Medical Center, Birmingham, AL 35233

* To whom correspondence should be addressed. E-mail: sjfrank{at}uab.edu.

Growth hormone receptor (GHR) is a cytokine receptor family member that responds to growth hormone (GH) by activation of the receptor-associated tyrosine kinase, JAK2. We previously showed that JAK2, in addition to being a signal transducer, dramatically increases the half-life of mature GHR, partly by preventing constitutive GHR downregulation. Herein we explored GHR and JAK2 determinants for both constitutive and GH-induced GHR downregulation, exploiting the previously characterized GHR- and JAK2-deficient {gamma}2A reconstitution system. We found that JAK2's ability to protect mature GHR from rapid degradation measured in the presence of the protein synthesis inhibitor, cycloheximide (CHX), depended on the presence of GHR's Box 1 element and the intact JAK2 FERM domain, but not the kinase-like or kinase domains of JAK2. Thus, GHR-JAK2 association, but not JAK2 kinase activity, is required for JAK2 to inhibit constitutive GHR downregulation and enhance GHR half-life. In cells that expressed JAK2, but not cells lacking JAK2, GH markedly enhanced GHR degradation. Like JAK2-induced protection from constitutive downregulation, GH-induced GHR downregulation required the GHR Box 1 element and an intact JAK2 FERM domain. However, a JAK2 mutant lacking the kinase-like and kinase domains did not mediate GH-induced GHR downregulation. Likewise, a kinase-deficient JAK2 was insufficient for this purpose, indicating that kinase activity is required. Both lactacystin (a proteasome inhibitor) and chloroquine (a lysosome inhibitor) blocked GH-induced GHR loss. Interestingly, GH-induced GHR ubiquitination, like downregulation, was prevented in cells expressing a kinase-deficient JAK2 protein. Further, a GHR mutant all of whose cytoplasmic tyrosine residues were changed to phenylalanines was resistant to GH-induced GHR ubiquitination and downregulation. Collectively, our data suggest that determinants required for JAK2 to protect mature GHR from constitutive degradation differ from those that drive GH-induced GHR downregulation. The latter requires GH-induced JAK2 activation and GHR tyrosine phosphorylation, and is correlated to GHR ubiquitination in our reconstitution system.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. G. S. Kumar, B. Varghese, A. Banerjee, D. P. Baker, S. N. Constantinescu, S. Pellegrini, and S. Y. Fuchs
Basal Ubiquitin-independent Internalization of Interferon {alpha} Receptor Is Prevented by Tyk2-mediated Masking of a Linear Endocytic Motif
J. Biol. Chem., July 4, 2008; 283(27): 18566 - 18572.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
X. Wang, J. Jiang, J. Warram, G. Baumann, Y. Gan, R. K. Menon, L. A. Denson, K. R. Zinn, and S. J. Frank
Endotoxin-Induced Proteolytic Reduction in Hepatic Growth Hormone (GH) Receptor: A Novel Mechanism for GH Insensitivity
Mol. Endocrinol., June 1, 2008; 22(6): 1427 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Yang, J. F. Langenheim, X. Wang, J. Jiang, W. Y. Chen, and S. J. Frank
Activation of Growth Hormone Receptors by Growth Hormone and Growth Hormone Antagonist Dimers: Insights into Receptor Triggering
Mol. Endocrinol., April 1, 2008; 22(4): 978 - 988.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society